Mercanto Holdings Inc. (TGSHF)
OTCMKTS · Delayed Price · Currency is USD
0.0033
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
Mercanto Holdings Revenue
Mercanto Holdings had revenue of 784.53K CAD in the quarter ending October 31, 2025, with 13.47% growth. This brings the company's revenue in the last twelve months to 3.09M, down -5.48% year-over-year. In the fiscal year ending July 31, 2025, Mercanto Holdings had annual revenue of 3.00M, down -23.05%.
Revenue (ttm)
3.09M CAD
Revenue Growth
-5.48%
P/S Ratio
2.67
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.88M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2025 | 3.00M | -897.42K | -23.05% |
| Jul 31, 2024 | 3.89M | 730.39K | 23.09% |
| Jul 31, 2023 | 3.16M | 1.95M | 160.30% |
| Jul 31, 2022 | 1.22M | 973.00K | 401.86% |
| Jul 31, 2021 | 242.13K | 45.21K | 22.96% |
| Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Trees | 14.50M |
| CV Sciences | 14.37M |
| CordovaCann | 10.20M |
| Cannabis Bioscience International Holdings | 148.34K |
| Rafarma Pharmaceuticals | 133.33K |
| Full Alliance Group | 82.12K |